HAEMONETICS
HAEMONETICS operates in Diversified Metals & Mining.
HAEMONETICS (HAZ) - Net Assets
Latest net assets as of September 2024: €878.85 Million EUR
Based on the latest financial reports, HAEMONETICS (HAZ) has net assets worth €878.85 Million EUR as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.53 Billion) and total liabilities (€1.65 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €878.85 Million |
| % of Total Assets | 34.8% |
| Annual Growth Rate | 3.8% |
| 5-Year Change | 63.51% |
| 10-Year Change | N/A |
| Growth Volatility | 12.69 |
HAEMONETICS - Net Assets Trend (2017–2024)
This chart illustrates how HAEMONETICS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for HAEMONETICS (2017–2024)
The table below shows the annual net assets of HAEMONETICS from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-03-31 | €959.96 Million | +17.35% |
| 2023-03-31 | €818.00 Million | +9.15% |
| 2022-03-31 | €749.42 Million | +2.43% |
| 2021-03-31 | €731.67 Million | +24.62% |
| 2020-03-31 | €587.11 Million | -12.09% |
| 2019-03-31 | €667.87 Million | -11.24% |
| 2018-03-31 | €752.43 Million | +1.73% |
| 2017-03-31 | €739.61 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to HAEMONETICS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 24.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €360.46 Million | 37.55% |
| Other Components | €599.50 Million | 62.45% |
| Total Equity | €959.96 Million | 100.00% |
HAEMONETICS Competitors by Market Cap
The table below lists competitors of HAEMONETICS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Longevity Health Holdings, Inc.
NASDAQ:XAGE
|
$516.88K |
|
Spermosens AB (publ)
F:9R5
|
$517.28K |
|
RJK Explorations Ltd
PINK:RJKAF
|
$517.37K |
|
Burcon NutraScience Corp
PINK:BRCNF
|
$518.20K |
|
Movinn AS
CO:MOVINN
|
$516.79K |
|
Iiot-Oxys Inc
PINK:ITOX
|
$516.62K |
|
Thai Enger Holding Public Company Limited
BK:TIGER
|
$516.38K |
|
New World Resources Limited
PINK:NWCBF
|
$516.36K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in HAEMONETICS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 817,997,000 to 959,959,000, a change of 141,962,000 (17.4%).
- Net income of 117,558,000 contributed positively to equity growth.
- Other factors increased equity by 24,404,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €117.56 Million | +12.25% |
| Other Changes | €24.40 Million | +2.54% |
| Total Change | €- | 17.35% |
Book Value vs Market Value Analysis
This analysis compares HAEMONETICS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.78x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.72x to 2.78x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | €14.15 | €52.60 | x |
| 2018-03-31 | €14.37 | €52.60 | x |
| 2019-03-31 | €13.09 | €52.60 | x |
| 2020-03-31 | €11.67 | €52.60 | x |
| 2021-03-31 | €14.38 | €52.60 | x |
| 2022-03-31 | €14.66 | €52.60 | x |
| 2023-03-31 | €16.21 | €52.60 | x |
| 2024-03-31 | €18.90 | €52.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently HAEMONETICS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.25%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.98%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 2.29x
- Recent ROE (12.25%) is above the historical average (8.35%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -3.55% | -2.96% | 0.72x | 1.67x | €-100.23 Million |
| 2018 | 6.06% | 5.04% | 0.73x | 1.64x | €-29.67 Million |
| 2019 | 8.24% | 5.69% | 0.76x | 1.91x | €-11.77 Million |
| 2020 | 13.03% | 7.74% | 0.78x | 2.16x | €17.82 Million |
| 2021 | 10.86% | 9.13% | 0.48x | 2.49x | €6.30 Million |
| 2022 | 5.79% | 4.37% | 0.53x | 2.48x | €-31.57 Million |
| 2023 | 14.11% | 9.87% | 0.60x | 2.37x | €33.60 Million |
| 2024 | 12.25% | 8.98% | 0.60x | 2.29x | €21.56 Million |
Industry Comparison
This section compares HAEMONETICS's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| HAEMONETICS (HAZ) | €878.85 Million | -3.55% | 1.87x | $516.82K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |